W. V. Ruyle

Publications

1.1K

Citations

H-Index

1952

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

W. V. Ruyle is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, organic chemistry, and molecular sciences.

Top concepts

PharmacologyOrganic ChemistryMolecular SciencesMedicineChemistryBiochemistryNatural SciencesEngineeringBioorganic ChemistryDrug Discovery

Publications per year

1952–1980

Publications

A new class of angiotensin-converting enzyme inhibitors

Arthur A. Patchett, Elbert E. Harris, Edward W. Tristram et al. · Nature · 1980 · 706 citations

Medicinal Chemistry, Medicine, Antihypertensive Therapy +5

Novel analgesic-antiinflammatory salicylates

John Hannah, W. V. Ruyle, H. Jones et al. · Journal of Medicinal Chemistry · 1978 · 81 citations

Medicinal Chemistry, Pharmaceutical Science, Anti-inflammatory +13

Discovery of diflunisal.

John Hannah, W. V. Ruyle, H. Jones et al. · British Journal of Clinical Pharmacology · 1977 · 55 citations · Full text

The Preparation of Δ<sup>7,9(11)</sup>-allo-Steroids by the Action of Mercuric Acetate on Δ<sup>7</sup>-allo-Steroids

W. V. Ruyle, Theodore A. Jacob, J. M. Chemerda et al. · Journal of the American Chemical Society · 1953 · 45 citations

Mercuric Acetate, Biosynthesis, Bioorganic Chemistry +13

Nucleosides I. A New Synthesis of 1-β-D-Arabinofuranosyl Pyrimidine Nucleosides

T. Y. Shen, H. M. Lewis, W. V. Ruyle · The Journal of Organic Chemistry · 1965 · 41 citations

Molecular Sciences, Bioorganic Chemistry, 1-β-D-arabinofuranosyl Pyrimidine Nucleosides +12

Rows per page

1–5 of 12